Achelois BioPharma develops curative, programmable Multivalent Therapeutics to treat cancer, viral infection, autoimmune, and inflammatory diseases. Unlike traditional drugs, which are designed to target a single molecule, multivalent therapeutics are designed to target a combination of molecules underlying complex human diseases. The Autocloner application assists scientists to discover and develop these novel treatments.
Oops!There is no article here.
Oops!There is no article here.
Oops!There is no article here.
Oops!There is no article here.
